Condition
Cholestatic Liver Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cholestatic Liver Disease clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Italy (2), Thailand (1)). By phase: Phase 1 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Cholestatic Liver Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Vitamin D2 with Calcitriol in kids with cholestasis and vitamin D deficiency | Phase 4 | Bangkok | Recruiting | Jun 26, 2026 |
| Finding genetic causes of adult-onset cholestatic liver disease | — | Milan, Milano | Recruiting | Jan 5, 2026 |
| Saroglitazar pharmacokinetics and safety in moderate cholestatic cirrhosis | Phase 1 | Indianapolis, Indiana | Recruiting | Feb 13, 2025 |
| Exploring genetic mutations linked to liver cancers and cholestatic diseases | — | Bologna, Bologna and 4 other locations | Recruiting | Jan 16, 2025 |
| Treatment for liver impairment in patients with cirrhosis from cholestatic liver disease | Phase 1 | Indianapolis, Indiana | Recruiting | Sep 16, 2021 |
All recruiting trials (5)
-
Vitamin D2 with Calcitriol in kids with cholestasis and vitamin D deficiency
This study tests whether adding calcitriol to vitamin D2 helps children with cholestasis and vitamin D deficiency reach healthier vitamin D levels.
-
Finding genetic causes of adult-onset cholestatic liver disease
This study uses whole-genome sequencing to try to find rare genetic causes in adults with unexplained cholestatic liver disease so care can be better tailored.
-
Saroglitazar pharmacokinetics and safety in moderate cholestatic cirrhosis
This tests whether taking saroglitazar 1 mg every other day is safe and how the drug behaves in adults with moderate cirrhosis from cholestatic liver disease.
-
Exploring genetic mutations linked to liver cancers and cholestatic diseases
This study is looking to see if certain genetic changes are more common in people with liver cancers and cholestatic diseases to help understand these conditions better.
-
Treatment for liver impairment in patients with cirrhosis from cholestatic liver disease
This study is testing a new medication called Saroglitazar Magnesium to see if it can improve liver function and health in people with cirrhosis from cholestatic liver disease.
Related topics
Quick answers
How many Cholestatic Liver Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Italy (2 trials), Thailand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.